We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes

This study has been terminated.
(Due to non-recruitment, the study is being halted. There are no major safety or tolerability concerns in the study conducted so far.)
Sponsor:
ClinicalTrials.gov Identifier:
NCT01674348
First Posted: August 28, 2012
Last Update Posted: August 5, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Piramal Enterprises Limited
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)